Methods For Conducting Magnetic Resonance Angiography Safely In Patients With Contraindications To Gadolinium
Nov 25th 2008Drug InformationDermatology
Nephrogenic systemic fibrosis (NSF) was first recognized in 1997 and described in 2000, and its association with gadolinium contrast agents was recognized in 2006. NSF is characterized by increased deposits of collagen, most frequently in the skin, but it can be systemic, and in severe cases fatal. There is no known consistently effective therapy. In 2006 and 2007 the U.S.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
